ICICI Prudential US Bluechip Equity Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 26-02-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - Growth 15.64 37.48 21.82 13.55 15.78 16.10
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 3.65 11.19 27.69 9.98 12.65 7.89

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - Growth Jul 06, 2012 21.82 13.55 15.78 2.01 2,949.16
Nippon India US Equity Opportunites Fund- Growth Plan- Growth Option Jul 23, 2015 36.60 10.97 14.63 2.42 642.55
Nippon India Japan Equity Fund- Growth Plan- Growth Option Aug 26, 2014 17.52 2.67 6.97 2.49 297.71
Franklin Asian Equity Fund - Growth Plan Jan 16, 2008 -0.71 -8.62 2.76 2.55 222.62
Aditya Birla Sun Life International Equity Fund - Growth - Regular Plan Oct 31, 2007 6.13 5.53 8.91 2.53 197.35

Fund Holdings as on 31-January-2024

  • Veeva Systems Inc

  • Walt Disney

  • Salesforce.Com Inc

  • Raytheon Technologies Corp

  • Allegion plc

  • Masco Corp.

  • Medtronic Plc

  • Comcast Corporation

  • Wells Fargo & Co

  • International Flavors & Fragrances Inc

  • Zimmer Biomet Holdings Inc

  • Campbell Soup Co

  • Nike Inc

  • US Bancorp Inc

  • Biogen Inc

  • Agilent Technologies Co Ltd

  • TERADYNE INC

  • Alphabet Inc

  • Charles Schwab Corp

  • Equifax Inc.

  • Tyler Technologies Inc

  • Intercontinental Exchange

  • TRANSUNION

  • Corteva Inc

  • Estee Lauder Cos Inc

  • ETSY INC

  • Pfizer Inc

  • 3M Co

  • Kellogg Co.

  • Gilead Sciences Inc.

  • MarketAxess Holdings Inc

  • ECOLAB INC

  • Polaris Industries Inc.

  • Amazon com

  • Emerson Electric

  • Bank of New York Mellon (US)

  • Keysight Technologies Inc

  • Thermo Fisher Scientific Inc

  • Altria Group Inc

  • Fortinet INC

  • Microsoft Corp

  • TREPS

  • Bristol-Myers Squibb Co

  • Honeywell Internation India Pvt Ltd

  • Microchip Technology Inc.

  • Blackrock (US)

  • Berkshire Hathway Inc. (US)

  • Net Current Assets

  • Bank of America Corp

  • Water Corp

  • Roper Technologies Inc

  • Cognizant Tech Solutions

  • Epam Systems Inc

  • Taiwan Semiconductor Mfg. Co. Ltd.

  • British American Tobacco PLC

  • Wk Kellogg Co

View More
  • Miscellaneous

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 06-Jul-2012 and currently has an AUM of ₹2,949.16 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended down ₹-0.35(-0.61%)yesterday to ₹56.92.

Among its top 3 holdings the fund has exposure to Veeva Systems Inc, and

The ICICI Prudential US Bluechip Equity Fund is managed by Rohan Maru and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100